MyndTec IncCanadian Securities Exchange:MYTC
- LAST PRICE0.0450
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.0200/ 5
- Ask / Lots0.0750/ 1
- Open / Previous Close--- / 0.0450
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
Nov 11, 2024
MyndTec Announces Exclusive License Agreement with Albany Medical College for AI-Based Spinal Cord Stimulation Technology, from 6:02PM ET on Monday Nov 11, 2024 by Dow Jones
6:02PM ET on Monday Nov 11, 2024 by Dow Jones
Oct 23, 2024
James Anderson Provides Update on Holdings of Myndtec Inc., from 5:36PM ET on Wednesday Oct 23, 2024 by Dow Jones
5:36PM ET on Wednesday Oct 23, 2024 by Dow JonesMyndTec Inc. Completes First Tranche of Non-Brokered Private Placement, from 5:25PM ET on Wednesday Oct 23, 2024 by Dow Jones
5:25PM ET on Wednesday Oct 23, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
MyndTec Inc | 1.1M | -1.0x | --- |
TruTrace Technologies Inc | 764.6K | -0.4x | --- |
Cognetivity Neurosciences Ltd | 887.2K | -0.1x | --- |
Aquarius Surgical Technologies Inc | 552.8K | -0.5x | --- |
Imaging Dynamics Co Ltd | 206.7K | -0.2x | --- |
Verisante Technology Inc | 659.1K | -4.9x | --- |
Company Information
MyndTec Inc. is a medical technology company. The Company focused on the development and commercialization of products that improve function, maximize independence, and enhance the quality of life for individuals who have suffered injury to the central nervous system as a result of stroke, spinal cord injury and certain traumatic brain injuries. Its flagship product is MyndMove, a patented and proprietary functional electrical stimulator that applies advanced principles of neuroplasticity and functional electrical stimulation to assist patients with paralysis of the arm and hand to make lasting gains in the recovery of natural and voluntary movement. It offers MyndMove devices to clinics and research institutions, as well as sells device parts or treatment supplies. It develops non-invasive neuro and nervous system electrical stimulation therapeutics for the treatment of neurological diseases specifically targeted to markets with large, growing, global patient populations.
Contact Information
- Headquarters
- 1900 Minnesota Court, Suite 122MISSISSAUGA, ON, Canada L5N 3C9
- Phone
- 905-363-0564
- Fax
- ---
Executives
- Interim Independent Chairman of the Board
- Milos Popovic
- Chief Executive Officer, Director
- Craig Leon
- Chief Financial Officer
- Scott Franklin
- Independent Director
- Harvey Griggs
- Independent Director
- William Jackson
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.1M |
|---|---|
Revenue (TTM) | $163.9K |
Shares Outstanding | 25.1M |
MyndTec Inc does not pay a dividend. | |
Beta | --- |
EPS | $-0.04 |
Book Value | $-0.04 |
P/E Ratio | -1.0x |
Price/Sales (TTM) | 6.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -664.56% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
